TERRENCE F. BLASCHKE

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

DURECT CORP

Filing Date Source Excerpt
2009-04-29 Dr. Blaschke is Professor of Medicine and Molecular Pharmacology at Stanford University School of Medicine.
2022-10-07 Includes 28,000 shares held by Terrence F. Blaschke and 3,000 shares held by the Terrence and Jeannette Blaschke Trust U/A dated November 11, 1993. Also includes 489,982 shares issuable upon exercise of options exercisable within 60 days of October 3, 2022.

Data sourced from SEC filings. Last updated: 2026-02-03